Amersham takes Optison to Europe
Ultrasound contrast agent Optison has been cleared for sale in the European Union. Amersham Health will begin marketing the echocardiography agent this month. The company obtained comarketing rights to the product from Mallinckrodt in
Ultrasound contrast agent Optison has been cleared for sale in the European Union. Amersham Health will begin marketing the echocardiography agent this month. The company obtained comarketing rights to the product from Mallinckrodt in 2000.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Recent Videos
Related Content
